Showing 2461-2470 of 2839 results for "".
- Revance Resubmits BLA for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-resubmits-bla-for-daxibotulinumtoxina/2473204/Revance Therapeutics, Inc. has resubmitted its Biologics License Application (BLA) to FDA for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The submission is in response to the Complete Response Letter (CRL) issued by FDA in October 2021. The
- Dr. J. Kevin Duplechain Named New President of AACShttps://modernaesthetics.com/news/dr-j-kevin-duplechain-named-new-president-of-aacs/2473198/Dr. J. Kevin Duplechain is the new President of the American Academy of Cosmetic Surgery (AACS) and its affiliate organization, the Cosmetic Surgery Foundation (CSF), the research and education arm of the
- Bellafill Marks Distribution of 1 Million Syringeshttps://modernaesthetics.com/news/bellafill-marks-distribution-of-1-million-syringes/2473197/At the close of 2021,
- Business News: Solta Medical Readies for IPOhttps://modernaesthetics.com/news/business-news-solta-medical-readies-for-ipo/2473195/Bausch Subsidiary Solta Medical Corporation is getting ready to go public. The Company publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed initial public offering ("IPO") of Solta's common shares.
- BTL Announces New EMFACE Facial Devicehttps://modernaesthetics.com/news/btl-announces-new-emface-facial-device/2473183/BTL has announced its latest technology innovation, which the company says is the result of combining many years of institutional knowledge of the simultaneous emission of radio frequency and electromagnetic energies. EMFACE™ utilizes a patented technology of muscle contraction and ski
- Business News: $511M SPAC Merger Deal for Sunevahttps://modernaesthetics.com/news/business-news-511m-spac-merger-deal-for-suneva/2473182/Suneva Medical, Inc. and Viveon Health Acquisition Corp., a special purpose acquisition company (SPAC), are joining forces to form a regenerative aesthetics company. Upon completion of the transaction, the combined company's securities are expected to be traded on the NYSE unde
- Does the "No Surprises Act" Apply to Aesthetic Services?https://modernaesthetics.com/news/does-the-no-surprises-act-apply-to-aesthetic-services/2473180/In a chat thread with colleagues on our mutual trade organizations' message board, there was a question about providing Good Faith Estimates (GFE) for aesthetic procedures under the No Surprises Act. I stated that I didn't think GFEs were required for aesthetic procedures, but a represent
- Obagi Rolls Out The Skintrinsiq System Devicehttps://modernaesthetics.com/news/obagi-rolls-out-the-skintrinsiq-system-device/2473178/Obagi is launching the Skintrinsiq device, its first entry into the complementary skincare device market. The Skintrinsiq system extracts impurities then infuses Obagi skincare products via treatment protocols customized for individual skincare needs. "The uni
- Placental Allograft Technology from MiMedx Shown Beneficial for Mohs Repairshttps://modernaesthetics.com/news/placental-allograft-technology-from-mimedx-shown-beneficial-for-mohs-repairs/2473174/MiMedx Group’s Purion® processed dHACM (Epifix®) placental allografts are associated with a statistically significant lower risk for infection, poor scar cosmesis, scar revision, and additional operation at the index site, when compared to traditional methods of incisional repair po
- Registration Open for AACS 2022 Annual Meetinghttps://modernaesthetics.com/news/registration-open-for-aacs-2022-annual-meeting/2473170/Registration is open for the American Academy of Cosmetic Surgery (AACS) 2022 Annual Scientific Meeting. Themed “Immerse in Perfection – Advances in Cosmetic Su